Joseph Collard
Inventor
Stats
- 80 US patents issued
- 131 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 80 US Patents Issued
- 131 US Applications Filed
- 328 Total Citation Count
- May 29, 2020 Most Recent Filing
- Oct 2, 2009 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
Cu RNA ,Inc. | 1
| 2011
|
OPKO CURNA, LLC | 2
2 | 2009
2010 |
OPKP CuRNA, LLC | 1
| 2010
|
CURNA, INC. | 6
46 34 3 3 31 44 12 11 | 2009
2010 2011 2012 2013 2014 2015 2016 2017 |
Inventor Addresses
Address | Duration |
---|---|
BELRAY BEACH, FL, US | Apr 02, 15 - Apr 02, 15 |
Belray Beach, FL, US | Jul 29, 14 - Jul 29, 14 |
DELRAY BEACH, FL, US | Jun 05, 14 - Jun 18, 15 |
Delray Beach, CA, US | Jun 07, 12 - Jun 07, 12 |
Delray Beach, FL, US | Apr 29, 10 - Jul 11, 23 |
Delray beach, FL, US | May 09, 13 - May 09, 13 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 113 |
A61L: | METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES | 2 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 37 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
11697814 | 2023 | Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene | 0 |
11408004 | 2022 | Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT) | 0 |
11390868 | 2022 | Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity | 0 |
11339394 | 2022 | Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene | 0 |
10995334 | 2021 | Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2 | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.